Literature DB >> 12653560

Interaction of an aromatic dibromoisothiouronium derivative with the Ca(2+)-ATPase of skeletal muscle sarcoplasmic reticulum.

M C Berman1, S J Karlish.   

Abstract

Isothiouronium compounds [Hoving, S., Bar-Shimon, M., Tijmes, J. J., Goldshleger, R., Tal, D. M., and Karlish, S. J. (1995) J. Biol. Chem. 270, 29788-29793] act as high-affinity competitive antagonists for Na(+) and K(+) (Rb(+)) on the renal Na(+)/K(+)-ATPase where they favor the E1 conformation. We have now characterized the effects of 1,3-dibromo-2,4,6-tris(methylisothiouronium)benzene (Br(2)-TITU) on the Ca(2+)-ATPase of skeletal muscle sarcoplasmic reticulum. Br(2)-TITU inhibited the Ca(2+)-ATPase, both transport and catalytic activity, with a K(0.5) of 5-15 microM. Maximum inhibition was at 10 min with t(0.5) of 3-5 min. Br(2)-TITU, 100 microM, quenched Trp autofluorescence by 80%, but the residual signal still responded to Ca(2+) binding. Maximum quenching of fluorescence was at pH 9.0. Total E-P levels, during the steady state of turnover of the Ca(2+)-ATPase, were increased from 0.5 to 5.8 nmol x mg(-1) by Br(2)-TITU at pH 6.8. Trinitrophenyl-ATP (TNP-ATP) superfluorescence, which monitors hydrophobicity of the ATP site, was increased 3-4-fold, suggesting that Br(2)-TITU favors an "E2"-like state. Fluorescence was also increased 3-5-fold when E-P was induced with P(i) plus EGTA. Br(2)-TITU increased the rate constants of induction of superfluorescence with ATP plus Ca(2+) from 0.32 to 0.69 s(-1) and with P(i) plus EGTA from 0.84 to 7.45 s(-1). Br(2)-TITU also decreased rate constants for "off" reactions from 2.9 to 0.66 s(-1) and from 10.9 to 0.73 s(-1) for the ATP and P(i) reactions, respectively. Br(2)-TITU, which competitively inhibits the Na(+)/K(+)-ATPase, has a novel effect on the Ca(2+)-ATPase. It promotes accumulation of E2-P species due to increased rate of formation and decreased rate of hydrolysis and quenches tryptophan autofluorescence. Br(2)-TITU could be a useful inhibitor to probe intermediate reactions of the Ca(2+)-ATPase that link catalysis with Ca(2+) translocation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12653560     DOI: 10.1021/bi026071n

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Effects of high-affinity inhibitors on partial reactions, charge movements, and conformational States of the Ca2+ transport ATPase (sarco-endoplasmic reticulum Ca2+ ATPase).

Authors:  Francesco Tadini-Buoninsegni; Gianluca Bartolommei; Maria Rosa Moncelli; Daniel M Tal; David Lewis; Giuseppe Inesi
Journal:  Mol Pharmacol       Date:  2008-01-22       Impact factor: 4.436

2.  The Ca2+-ATPase (SERCA1) is inhibited by 4-aminoquinoline derivatives through interference with catalytic activation by Ca2+, whereas the ATPase E2 state remains functional.

Authors:  Gianluca Bartolommei; Francesco Tadini-Buoninsegni; Maria Rosa Moncelli; Sandra Gemma; Caterina Camodeca; Stefania Butini; Giuseppe Campiani; David Lewis; Giuseppe Inesi
Journal:  J Biol Chem       Date:  2011-09-13       Impact factor: 5.157

3.  Discovery of novel SERCA inhibitors by virtual screening of a large compound library.

Authors:  Christopher Elam; Michael Lape; Joel Deye; Jodie Zultowsky; David T Stanton; Stefan Paula
Journal:  Eur J Med Chem       Date:  2011-02-25       Impact factor: 6.514

4.  Cyclopiazonic acid is complexed to a divalent metal ion when bound to the sarcoplasmic reticulum Ca2+-ATPase.

Authors:  Mette Laursen; Maike Bublitz; Karine Moncoq; Claus Olesen; Jesper Vuust Møller; Howard S Young; Poul Nissen; J Preben Morth
Journal:  J Biol Chem       Date:  2009-03-16       Impact factor: 5.157

Review 5.  Studies of Ca2+ ATPase (SERCA) inhibition.

Authors:  Giuseppe Inesi; Suming Hua; Cheng Xu; Hailun Ma; Malini Seth; Anand M Prasad; Carlota Sumbilla
Journal:  J Bioenerg Biomembr       Date:  2005-12       Impact factor: 3.853

6.  1,2-Dichlorobenzene affects the formation of the phosphoenzyme stage during the catalytic cycle of the Ca(2+)-ATPase from sarcoplasmic reticulum.

Authors:  Javier Vargas-Medrano; Jorge A Sierra-Fonseca; Luis F Plenge-Tellechea
Journal:  BMC Biochem       Date:  2016-03-11       Impact factor: 4.059

Review 7.  Drug Interactions With the Ca2+-ATPase From Sarco(Endo)Plasmic Reticulum (SERCA).

Authors:  Francesco Tadini-Buoninsegni; Serena Smeazzetto; Roberta Gualdani; Maria Rosa Moncelli
Journal:  Front Mol Biosci       Date:  2018-04-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.